Great discussion (NEU) team!
is there any precedence of a CEO/Board rejecting a low-ball T/O offer and informing the market of this? Are these generally kept quiet or announced?
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
NEU
neuren pharmaceuticals limited
Add to My Watchlist
5.34%
!
$13.21

Neuren Media and Analyst Coverage, page-1507
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.21 |
Change
0.670(5.34%) |
Mkt cap ! $1.640B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $18.28M | 1.342M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 420 | $13.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.21 | 55 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 309 | 13.190 |
8 | 252 | 13.180 |
6 | 1089 | 13.170 |
4 | 553 | 13.160 |
5 | 763 | 13.150 |
Price($) | Vol. | No. |
---|---|---|
13.200 | 187 | 3 |
13.210 | 396 | 2 |
13.220 | 1375 | 4 |
13.230 | 1100 | 3 |
13.240 | 1339 | 4 |
Last trade - 15.56pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online